X4 Pharmaceuticals Inc (NAS:XFOR)
$ 0.371 -0.022 (-5.6%) Market Cap: 63.27 Mil Enterprise Value: 10.25 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 30/100

Q3 2021 X4 Pharmaceuticals Inc Earnings Call Transcript

Nov 04, 2021 / 01:05PM GMT
Release Date Price: $5.15 (-8.04%)
Operator

Greetings and welcome to X4 Pharmaceuticals Third Quarter Financial and Operating Results Conference Call.

(Operator Instructions).

It is now my pleasure to introduce your host Dan Ferry of LifeSci Advisors. Please begin.

Dan Ferry
LifeSci Advisors - Managing Director

Thank you operator and good morning everyone. Thanks for joining us. Presenting on today's call will be X4's Chief Executive Officer Dr. Paula Ragan and the company's Chief Financial Officer Adam Mostafa.

Following prepared remarks by each we will open the call to your questions. And we'll be joined by Chief Scientific Officer Art Taveras, Chief Medical Officer Diego Cadavid and Chief Operating Officer Mary DiBiase.

As a reminder on today's call the company will be making forward looking statements regarding regulatory and product development plans as well as research activities. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted.

A description of these risks can be found in X4's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot